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discomfort and only 8% (7/87) had hand, foot and mouth disease.
According to our previous clinical studies, symptomatic enterovirus 71
(EV71) infection can progress through four stages: HFMD/herpangina (Stage
1), CNS involvement (Stage 2), cardiopulmonary failure (Stage 3), and
convalescence (Stage 4). Most EV71 cases in those studies stayed at stage 1,
some progressed to Stage 2 and a few would advance to the most severe
condition, Stage 3. We did autopsy for an EV71 fatal case. The brainstem
pathology showed neuronophagia and immune-histochemical stain showed
EV71 infected neurons, neuron loss. The most significantly risk factors
associated with CNS involvement were fever> Z 3 days and lethargy. Risk
factors for pulmonary edema after CNS involvement are hyperglycemia,
leukocytosis, and limb weakness. Hyperglycemia is the most significant
prognostic factor for pulmonary edema.
In the follow-up study of severe EV71 cases, 18 (64%) of the 28 cases with
cardiopulmonary failure after CNS involvement had limb weakness and
atrophy, 17 (61%) required tube feeding, and 16 (57%) required ventilator
support. Delayed neurodevelopment was found in only 1 (5%) case with
severe EV71 CNS involvement and in 21 (75%) cases with cardiopulmonary
failure (p < 0.001). Children with cardiopulmonary failure after CNS
involvement scored lower on intelligence tests than children with CNS
involvement alone (pZ 0.003). Among patients with CNS involvement alone,
children infected at ages younger than 2 had lower verbal comprehension
than children infected at older ages (pZ 0.009). EV71 CNS involvement with
cardiopulmonary failure may be associated with neurological sequelae,
delayed neurodevelopment and reduced cognitive functioning. Children
with CNS involvement without cardiopulmonary failure did well in neuro-
development. The rate of elevated attention-deficit/hyperactivity disorder-
related symptoms among children with enterovirus 71 central nervous
system infection was 20%, whereas that rate among matched control
subjects was only 3%. They also had more internalizing problems. Entero-
virus 71 central nervous system infection may affect long-term regulation of
attention and emotion and cause hyperactivity-impulsivity in children.
In conclusion, most EV71 cases are HFMD and recovered. Some (possible 1%)
progressed to Stage 2 encephalomyelitis, and 20e30% of cases with
encephalomyelitis may progress to cardiopulmonary failure because of
brainstem encephalitis and SIRS. Even under modern intensive care, 30%
of them would die and many of the survivors would have neurological
sequelae. After poliovirus was nearly eradicated by vaccination, EV71 is now
considered one of the most important enteroviruses. Therefore, continuous
surveillance of its occurrence, investigation of its virulence and its trans-
mission are all warranted to improve the future control. Development of
EV71 vaccine are ongoing and we hope for success in the near future.SYMPOSIUM 11 (SP 11)
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WHAT WENT WRONG IN WEST AFRICA AND WHERE ARE WE HEADED
Dale Fisher. Professor of Medicine and Head of the Infectious Diseases
Division at the National University Hospital, Singapore
The Ebola outbreak in West Africa is simply staggering in so many respects.
Originating in a rural town Meliandou in Guinea it could have been like any
other Ebola outbreak. A single animal to human transmission with some
degree of human to human spread most notably at funerals to family
members or hospitals to health care workers. Typical outbreaks last months,
they are contained fairly locally and eventually controlled by a fairly
standard approach rolled out by MSF. However this outbreak is different
with never before seen scale in terms of case numbers and deaths. There are
many reasons to explain this outcome almost all related to the setting in this
part of Africa and human factors.
Movement in this area is not difficult and as people become frightened and
witness death it is not surprising that people drive across the country to see
family despite being sick and despite the advice. For this reason the
geographic spread has been difficult to curtail, although limiting it (by and
large) to the 3 most affected countries is a true success story of work done in
Mali, Nigeria and other bordering countries.
Infection control, case management and social mobilization efforts have had
to likewise geographically pursue the outbreak. Necessarily this has seen the
evolution of novel and community based case management strategies as thecommunity is the regular front line while waiting for treatment units to be
established.
There is belief that zero cases can be reached and that Ebola virus disease
will not become endemic but that is not guaranteed and ongoing efforts that
continuously adapt to circumstances will need to be maintained for some
time yet.SP 11-2
EBOLA BIO-SAFETY AND LABORATORY TESTING
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Ebola outbreak in 2014-e2015, the largest in history of Ebola infection,
mainly affected a few countries in West Africa. According to the World
Health Organization, over 21,700 Ebola cases have been reported in nine
countries and over 8,640 people have died. According to the United States
Centers for Disease Control and Prevention (CDC), a few imported cases and
locally acquired cases in healthcare workers were reported in the US
(http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/index.html).
CDC provided the infection prevention and control recommendations and
guidance for caring hospitalized patients under investigation (PUI) for Ebola
Virus Disease (EVD) in U.S. hospitals. It’s important to follow standard
contact and droplet precautions when caring for a PUI or patient with
confirmed EVD. CDC updated personal protective equipment (PPE) portion of
the guidance based on the experience of treating patients with EVD in US
hospitals including Emory University Hospital. The procedures for putting on
(Donning) and removing (Doffing) is posted (http://www.cdc.gov/vhf/
ebola/hcp/procedures-for-ppe.html).
Procedures that could increase environmental contamination with infectious
materials such as body fluid and contaminated medical supplies and
equipment or create aerosols should be minimized. CDC lists key compo-
nents of standard, contact, and droplet precautions recommended for
healthcare personnel working in healthcare settings who have the potential
for exposure to patients and/or to infectious materials. For patient care
considerations, it is best to limit the use of needles and other sharps as much
as possible, keep the phlebotomy, procedures, and laboratory testing to the
minimum necessary for essential diagnostic evaluation and medical care.
Rapid laboratory tests for diagnosis of Ebola and/or malaria have been
developed and used. In addition, rapid tests using point-of-care type
analyzers for monitoring electrolytes, respiratory status, liver function,
plates are available for patient management.SP 11-3
FIGHT AGAINST EBOLA: PREPAREDNESS AND PUBLIC HEALTH RESPONSE
Yi-Chun Lo, MD. Taiwan Centers for Disease Control, Taiwan
On August 8, 2014, the World Health Organization announced the outbreak
of Ebola virus disease (EVD) in West Africa a public health emergency of
international concern under the authority of the International Health
Regulations (2005) and issued recommendations for affected and non-
affected countries regarding preparedness and response against Ebola.
Countries without domestic Ebola transmission are requested to establish
core capacities to prevent, detect, characterize and respond quickly,
efficiently and in a coordinated manner to the EVD threats in order to
reduce mortality and morbidity. A comprehensive risk assessment based on
well-established criteria would guide countries to determine timing to active
the preparedness and response plan.
This talk will address international and domestic preparedness and response
against Ebola using the successful story of Nigeria during July 23 to October
20, 2014, as an example. A key element for successful EVD control was the
rapid response for activating an Ebola Emergency Operations Center (EOC)
by using the Incident Management System (IMS). The EOC effectively
coordinated all available public health resources and applied real-time
technology in contact tracing and logistics management. Difficult contact
tracing was handled with the assistance of psychosocial support team and
social mobilization by conducting house-to-house visiting. The alert and
rumor surveillance helped discover new cases.
In response to the Ebola outbreak, the Taiwan Centers for Disease Control
(TCDC) had issued travel alert and taken measures for preparedness and
response since early April, 2014. On August 8, TCDC upgraded the response
